Possible Cardiovascular Dangers With Celebrex

First, it was Vioxx. Then, it was Bextra. After today's announcement by Pfizer, it could be three strikes and Cox-2 inhibitors are OUT! Based on an analysis of a large, long-term cancer trial, Pfizer admitted Celebrex more than doubled one's risk of a heart attack. One caveat: The Adenoma Prevention with Celecoxib (APC) cancer trial studied Celebrex at doses of 400 to 800 mg per day. As you can imagine, Pfizer's stock dropped some 14 percent after the news of the trial, sponsored by...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports